How we prove an L-leucine lot is the L form
Proving an L-leucine lot is a process of elimination. The assay measures quantity, the rotation measures handedness, the chromatogram separates leucine from its isomers, and the document chain ties the results to the drum. None of the four is sufficient alone.
The L form is established by four results that agree, not by one line on a certificate.
The four identity layers
| Check | Evidence | What it establishes | What it leaves open |
|---|---|---|---|
| Document | COA, lot code, manufacturer | Traceability from the drum to the release record | Does not prove the powder in the drum |
| Class | Appearance, solubility, pH, ninhydrin, IR | An amino acid is present; IR gives a fingerprint | Ninhydrin cannot distinguish one amino acid from another |
| Quantity | Titration, HPLC | How much amino acid is present; HPLC separates the isomers | Titration counts every amino group; HPLC needs a standard |
| Chirality | Specific rotation, chiral HPLC | L, D or a mixture | Rotation is not a chiral purity assay unless the conditions are fixed |
IR is the practical centre of the class layer. Leucine, isoleucine and valine are all white crystalline amino acids that look alike in a drum, so the IR spectrum is often the first test that separates them; ninhydrin only confirms that an amino acid is present. Compare it with a reference run on the same instrument.
The rotation, read as a ratio
Specific rotation normalises the polarimeter reading for cell length and concentration, so a value can be compared across laboratories. The catalog window is +14.9° to +17.3° on the dried basis. The D form rotates in the opposite direction, and the racemic DL mixture sits close to zero, so the sign and the magnitude together say how far the lot is from racemic. A value in the window is what an L lot should show; a value at zero is not L-leucine.
Dissolve 0.5 g in 100 mL and read it in a 1 dm tube: a specific rotation of +16° becomes an observed +0.08°. Temperature, dissolution and cell cleanliness all matter at that scale, so the certificate must print the solvent, concentration, temperature and basis. A rotation without those conditions cannot be checked.
The window is an identity gate, not a chiral purity specification. A lot at the lower edge is still inside the specification, and the figure moves with the method. If the brief needs a limit on the D form, write a chiral HPLC limit into the specification rather than reading one into the rotation.
What X-ray diffraction adds, and what it cannot see
XRD records how the solid scatters X-rays. A crystalline lot produces sharp reflections at defined angles, and the pattern identifies the solid form; an amorphous carrier gives no sharp pattern, and a different crystalline substance gives a different pattern. For a blend, XRD can show the superimposed patterns of the components and can detect a crystalline excipient that the certificate does not mention.
XRD cannot tell L-leucine from D-leucine. Enantiomers share the same lattice dimensions and powder pattern, so handedness is invisible to the method. Use XRD when the question is the solid form or the presence of a crystalline second phase, and use rotation or chiral HPLC when the question is the hand.
For routine release, IR and rotation do the identity work; XRD is an investigation tool for a new source or a disputed solid form. The method is described in the XRD note.
The routes that pass an assay
| Adulterant | What still passes | What catches it |
|---|---|---|
| DL-leucine | Assay, appearance, pH, loss on drying | Rotation falls toward zero; chiral HPLC confirms the D form |
| L-isoleucine | Titration assay, ninhydrin, appearance | Rotation is far outside the leucine window; HPLC and IR separate it |
| L-valine | Titration assay, ninhydrin, appearance | Rotation outside the window; HPLC and IR separate it |
| Norleucine | Titration assay, appearance | HPLC retention and IR; rotation alone is not decisive |
| BCAA blend | Total titration can sit inside 98.5–101.5% | Three peaks in the amino-acid profile, and a ratio that does not match a single substance |
| Water | As-is assay falls; the dried-basis correction can bring it back into the window | Loss on drying, read with the as-is result |
| Inorganic salts | As-is assay falls; residue rises | Residue on ignition |
The blend route is the one that catches buyers who rely on the assay alone. Leucine, isoleucine and valine are isomers or homologues with the same amino-acid backbone, and a mixture can be built to titrate inside the leucine window. The certificate's single assay line cannot see the difference; the chromatogram can, and the rotation may.
The water route is quieter. Added water lowers the as-is assay and raises the loss on drying; the dried-basis correction can hide the water from a reader who looks only at the corrected figure. Read the as-is result, the loss on drying and the residue together.
Writing identity into the specification
The specification should name L-leucine, CAS 61-90-5 and the formula C6H13NO2, then fix the four layers in writing: identification by IR against a reference and by ninhydrin; titration assay at 98.5–101.5% on the dried basis; rotation +14.9° to +17.3° with the solvent, concentration and temperature stated; and pH 5.5–6.5 for a 5% solution. The pH is a consistency check rather than an identity test: several amino acids sit in the same window, but a reading outside it points to residual acid or base. Loss on drying, residue, mesh, metals and micro complete the release sheet.
Two optional lines help when the brief is strict. A chiral HPLC limit on D-leucine makes chiral purity quantitative. An amino-acid profile limit stops a blended lot; a related-substance limit stops a reworked one. Neither line is on the catalog specification, and both can be agreed for a project.
The release lines are described on the COA page, and the grade question is on the grade page.
Five questions for a supplier
- What is the assay method, and is the result reported on the dried basis?
- What is the specific rotation, with the solvent, concentration and temperature used?
- Can you send the chromatogram that separates leucine from isoleucine and valine?
- Is the lot free L-leucine or a blend, and what name goes on the label?
- Who manufactured the lot, and do the certificate, the drum and the retained sample carry the same lot code?
An answer that repeats the specification without a method or a chromatogram is not an answer; the supplier who can produce all four layers is the one to keep. The market rules that follow the identity are on the compliance page, the comparison with a blend is on the L-leucine versus BCAA page, the IR method is described in the FTIR note, and the catalog specification is on the product page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation